Moreover, sanguinarine and other BZD inhibited the P-glycoprotein/ABCB1 and related ABCB5 in drug resistance in multidrug-resistant tumor lines, increasing their sensitivity to cytotoxic drugs, which might allow for better treatments [84]. The gene discussed is ABCB5; the disease is neoplasm.